Predicting the effectiveness of omalizumab in patients with refractory chronic rhinosinusitis with nasal polyps comorbid with asthma based on inflammatory biomarkers

Background: The treatment of refractory chronic rhinosinusitis with nasal polyps (CRSwNP) with omalizumab has been well studied based on clinical evaluation. Nevertheless, ideal quantitative or qualitative biomarkers for predicting a different response to biologics urgently need to be explored. We a...

Description complète

Détails bibliographiques

Auteurs principaux:	Yutong Sima, MD, Ming Zheng, MD, Yan Zhao, PhD, Siqi Ge, PhD, Chengyao Liu, MD, Ping Wang, BS, Xiangdong Wang, MD, PhD, Luo Zhang, MD, PhD
Format:	Artigo
Langue:	Inglês
Publié:	Elsevier 2025-01-01
Collection:	World Allergy Organization Journal
Sujets:	Chronic rhinosinusitis with nasal polyps Omalizumab Endotype Prediction
Accès en ligne:	http://www.sciencedirect.com/science/article/pii/S1939455124001418
Tags:	Ajouter un tag Pas de tags, Soyez le premier à ajouter un tag!